These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 17573603

  • 1. Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.
    Joglekar N, Joshi S, Kakde M, Fang G, Cianciola M, Reynolds S, Mehendale S, HIV Prevention Trial Network 047 Protocol Team.
    AIDS Care; 2007 Jul; 19(6):817-21. PubMed ID: 17573603
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.
    Joglekar NS, Joshi SN, Deshpande SS, Parkhe AN, Katti UR, Mehendale SM.
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):412-5. PubMed ID: 20096909
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
    El-Sadr WM, Mayer KH, Maslankowski L, Hoesley C, Justman J, Gai F, Mauck C, Absalon J, Morrow K, Mâsse B, Soto-Torres L, Kwiecien A.
    AIDS; 2006 May 12; 20(8):1109-16. PubMed ID: 16691061
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050).
    Carballo-Diéguez A, Balán IC, Morrow K, Rosen R, Mantell JE, Gai F, Hoffman S, Maslankowski L, El-Sadr W, Mayer K.
    AIDS Care; 2007 Sep 12; 19(8):1026-31. PubMed ID: 17852000
    [Abstract] [Full Text] [Related]

  • 8. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.
    Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Mâsse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L, HPTN 050 Protocol Team.
    AIDS; 2006 Feb 28; 20(4):543-51. PubMed ID: 16470118
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH, Blanchard K, Chaikummao S, Friedland BA, Srivirojana N, Connolly C, Witwatwongwana P, Supawitkul S, Mock PA, Chaowanachan T, Tappero J.
    Sex Transm Dis; 2008 Mar 28; 35(3):226-32. PubMed ID: 18490865
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
    Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.
    Contraception; 2009 Nov 28; 80(5):484-92. PubMed ID: 19835725
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
    Nel AM, Mitchnick LB, Risha P, Muungo LT, Norick PM.
    J Womens Health (Larchmt); 2011 Aug 28; 20(8):1207-14. PubMed ID: 21774672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
    Hoffman S, Morrow KM, Mantell JE, Rosen RK, Carballo-Diéguez A, Gai F.
    Arch Sex Behav; 2010 Jun 28; 39(3):748-60. PubMed ID: 19636696
    [Abstract] [Full Text] [Related]

  • 18. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi.
    Woodsong C, Alleman P.
    AIDS Educ Prev; 2008 Apr 28; 20(2):171-87. PubMed ID: 18433322
    [Abstract] [Full Text] [Related]

  • 19. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL, Hart CW.
    AIDS Behav; 2010 Jun 28; 14(3):600-6. PubMed ID: 20049522
    [Abstract] [Full Text] [Related]

  • 20. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.
    BMC Res Notes; 2012 Nov 01; 5():613. PubMed ID: 23116431
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.